Researchers at Case Western Reserve University School of Medicine have developed a method that could make magnetic resonance imaging—MRI—multicolor.
Current MRI techniques rely on a single contrast agent injected into a patient’s veins to vivify images. The new method uses two at once, which could allow doctors to map multiple characteristics of a patient’s internal organs in a single MRI. The strategy could serve as a research tool and even aid disease diagnosis.
“The method we developed enables, for the first time, the simultaneous detection of two different MRI contrast agents,” said Chris Flask, PhD, Associate Professor of Radiology, Biomedical Engineering, and Pediatrics, and Director of the Imaging Resource Core at Case Western Reserve University School of Medicine. Two contrast agents could include one specifically targeting diseased tissue, and one designed to show healthy tissue, for example. The new method would enable immediate comparisons of how each agent distributes in the same patient.
“This multi-agent detection capability has the potential to transform molecular imaging, as it provides a critical translational pathway for studies in patients,” said Flask. It also provides a unique imaging platform to rigorously study molecular therapies.” Therapies could include those targeting biomarkers or other detectable molecules associated with diseases.
Flask and colleagues recently described their new method in Nature Scientific Reports. The paper describes how two contrast agents, gadolinium and manganese, can be detected and independently quantified during MRIs. The authors span 11 departments at Case Western Reserve, uniting engineers, nurses, clinicians, and basic science researchers. They also include several members of the Case Comprehensive Cancer Center. According to the authors, their results provide “an adaptable, quantitative imaging framework to assess two MRI contrast agents simultaneously for a wide variety of imaging applications.”
The researchers have begun to investigate widespread practical applications for the new MRI approach. Said Flask, “In this initial paper, we validated our new methodology, opening the possibility for numerous follow-on application studies in cancer, genetic diseases such as cystic fibrosis, and metabolic diseases such as diabetes.”
Learn more: Multicolor MRIs Could Aid Disease Detection
The Latest on: Multicolor MRIs
- The Global Contrast Media Market size is expected to reach $6.3 billion by 2025, rising at a market growth of 3.52% CAGR during the forecast periodon March 20, 2020 at 5:36 pm
New York, March 20, 2020 -- Reportlinker.com announces the release of the report "Global Contrast Media Market By Product Type By Application By Modality By Region, Industry.
- Global Contrast Media Market Analysis Report, 2020on March 20, 2020 at 5:24 pm
Dublin, March 20, 2020 -- The "Global Contrast Media Market, by Product Type, by Application, by Modality, by Region, Industry Analysis and Forecast, 2019 - 2025" report.
- Multi-scale resting state functional reorganization in response to multiple sclerosis damage.on March 20, 2020 at 10:12 am
Patients and 42 healthy controls underwent a multimodal 3 T MRI, including resting-state functional MRI. We identified 16 resting-state networks via independent component analysis and measured ...
- Intraoperative Imaging Market Report Puts Limelight On Growth, Opportunities By Coherent Market Insightson March 19, 2020 at 2:40 am
Global Intraoperative Imaging Market Intraoperative imaging devices and systems are employed for localizing ...
- Repeatability and Reproducibility of Pancreas Volume Measurements Using MRIon March 17, 2020 at 7:40 pm
Reduced pancreas volume, as measured by non-contrast magnetic resonance imaging (MRI), is observed in individuals with newly-diagnosed type 1 diabetes (T1D) and declines over the first year after ...
- Breast tumor movements analysis using MRI scans in prone and supine positionson March 17, 2020 at 6:19 am
For breast cancer patients, breast-conserving surgery (BCS) has the advantage of improving cosmetic satisfaction and quality of life compared with mastectomy. Because the tumor-positive margin in BCS ...
- $3 million grant may help reduce unnecessary breast biopsieson March 12, 2020 at 11:22 am
An academic-industry partnership spearheaded by engineers at Dartmouth College’s Thayer School of Engineering has received a $3 million grant from the National Cancer Institute to pursue development ...
- NeuroPace RNS System for Epilepsy Gets FDA Approval for MRI Labelingon March 10, 2020 at 12:41 pm
Because MRI scans are often used to monitor patients with brain anomalies that may contribute ... Treatment with the RNS System has been shown in a multi-center retrospective study to produce a median ...
- Multi-Modal Breast Imaging Platform (image)on March 6, 2020 at 8:44 am
Dartmouth engineers received a grant from the National Cancer Institute to pursue the idea of developing a multi-modal breast ... uses Microwave and Magnetic Resonance Imaging (sMMRI), a first ...
- MR Solutions’ dry magnet MRI system for molecular imaging on display at EMIM 2020on March 2, 2020 at 4:00 pm
GUILDFORD, UNITED KINGDOM - Mar 3, 2020 - MR Solutions will be displaying its latest dry magnet 3T to 9.4T preclinical, multi-modality MRI (with PET or SPECT) and new benchtop PET/CT systems to the ...
via Google News and Bing News